Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 16 , ISSUE 5 ( September-October, 2024 ) > List of Articles

CASE REPORT

Maternal Myasthenia Gravis: A Case Report

Mary Devasiya, Akshaya Murali, Anitha Santosh, Madhu Swetha Sharma

Keywords : Case report, Fetomaternal outcomes, Myasthenia gravis, Neurological disorder

Citation Information : Devasiya M, Murali A, Santosh A, Sharma MS. Maternal Myasthenia Gravis: A Case Report. J South Asian Feder Obs Gynae 2024; 16 (5):576-577.

DOI: 10.5005/jp-journals-10006-2512

License: CC BY-NC 4.0

Published Online: 23-10-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Introduction: Myasthenia gravis (MG) is an acquired neuromuscular disorder that presents with clinical weakness and fatigue of the skeletal muscles. Pregnancy can have significant effects on the course of myasthenia gravis. Patients with well-controlled MG prior to conception usually have a benign disease course during pregnancy, although a small number may deteriorate during the postpartum period. Case description: A 22-year-old primigravida was referred to our hospital for further antenatal management, as she was a known case of MG. Myasthenia gravis was diagnosed at the age of 17, when she developed drooping of eyelids, and weakness of both upper and lower limbs. Acetylcholine receptor antibodies were positive. Her symptoms improved with oral prednisolone and pyridostigmine, but caused bilateral avascular necrosis of the hip requiring core decompression surgery. She further required thymectomy a year later. The patient's myasthenic symptoms were well-controlled prior to conception and she remained asymptomatic throughout pregnancy while continuing pyridostigmine. She underwent an elective cesarean section at 39 weeks of pregnancy due to her prior history of avascular necrosis of bilateral hip and her postpartum period was uneventful. Conclusion: Pregnancies associated with MG can have a stable disease course if adequately stabilized with drugs or thymectomy prior to pregnancy. Antenatal management by a multidisciplinary approach, along with appropriate immunosuppressants can improve both maternal and neonatal outcomes.


PDF Share
  1. Téllez-Zenteno JF, Hernández-Ronquillo L, Salinas V, et al. Myasthenia gravis and pregnancy: Clinical implications and neonatal outcome. BMC Musculoskelet Disord 2004;5:42. DOI: 10.1186/1471-2474-5-42.
  2. Norwood F, Dhanjal M, Hill M, et al. Myasthenia in pregnancy: Best practice guidelines from a UK multispecialty working group. J Neurol Neurosur Psychiatry 2014;85(5):538–543.
  3. Hamel J, Ciafaloni E. An Update: Myasthenia gravis and pregnancy. Neurol Clin 2018;36(2):355–365. DOI: 10.1016/j.ncl.2018.01.005.
  4. Evoli A, Tonali PA, Padua L, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003;126(Pt 10):2304–2311. DOI: 10.1093/brain/awg223.
  5. Chaudhry SA, Vignarajah B, Koren G. Myasthenia gravis during pregnancy. Can Fam Physician 2012;58(12):1346–1349. PMID: 23242891.
  6. Inoue KI, Tsugawa J, Fukae J, et al. Myasthenia gravis with anti-muscle-specific tyrosine kinase antibody during pregnancy and risk of neonatal myasthenia gravis: A case report and review of the literature. Case Rep Neurol 2020;12(1):114–120. DOI: 10.1159/000506189.
  7. Aitken A, Kanitkar S. New diagnosis of myasthenia gravis in the third trimester – A case report. Case Rep Womens Health 2023;38:e00505. DOI: 10.1016/j.crwh.2023.e00505.
  8. Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: Emerging clinical and biological heterogeneity. Lancet Neurol 2009;8(5):475–490. DOI: 10.1016/S1474-4422(09)70063-8.
  9. Gilhus NE. Treatment considerations in myasthenia gravis for the pregnant patient. Expert Rev Neurothe 2023;23(2):169–177. DOI: 10.1080/14737175.2023.2178302.
  10. Berlit S, Tuschy B, Spaich S, et al. Myasthenia gravis in pregnancy: A case report. Case Rep Obstet Gynecol 2012;2012:736024. DOI: 10.1155/2012/736024.
  11. Assudani L, Notwani A. Myasthenia gravis in pregnancy: A case report. Int J Reprod Contracept Obstet Gynecol 2023;12(1):264–267. DOI: 10.18203/2320-1770.ijrcog20223508.
  12. Ducci RD, Lorenzoni PJ, Kay CS, et al. Clinical follow-up of pregnancy in myasthenia gravis patients. Neuromuscul Disord 2017;27(4):352–357. DOI: 10.1016/j.nmd.2017.01.021.
  13. Su M, Liu X, Wang L, et al. Risk factors for pregnancy-related clinical outcome in myasthenia gravis: A systemic review and meta-analysis. Orphanet J Rare Dis 2022;17(1):52. DOI: 10.1186/s13023-022-02205-z.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.